Albemarle
$104.59Change from previous close: −0.42%Absolute change: −$0.44
At a glance
- Revenue growth
- −4.37%
- 2025 vs 2024
- Net margin
- -9.9%
- 2024: -21.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 5,143 | 5,378 | 9,617 | 7,320 |
| Cost of revenue | 4,474 | 5,315 | 8,431 | 4,246 |
| Gross profit | 669 | 62.5 | 1,186 | 3,075 |
| Selling, general and administrative | 550 | 618 | 910 | 524 |
| Research and development | 51.4 | 86.7 | 85.7 | 72.0 |
| Operating income | 67.3 | -642 | 190 | 2,478 |
| EBIT | -344 | -1,598 | 363 | 2,556 |
| EBITDA | 314 | -1,010 | 793 | 2,857 |
| Interest expense | 208 | 166 | 116 | 123 |
| Pre-tax income | -552 | -1,764 | 247 | 2,433 |
| Income tax | 157 | 87.1 | 430 | 391 |
| Net income | -511 | -1,179 | 1,573 | 2,690 |
| Net income to common shareholders | -677 | -1,316 | 1,573 | 2,690 |
| Basic EPS | -5.76 | -11.20 | 13.41 | 22.97 |
| Diluted EPS | -5.76 | -11.20 | 13.36 | 22.84 |
| Average shares (basic) | 118 | 118 | 117 | 117 |
| Average shares (diluted) | 118 | 118 | 118 | 118 |